If you have a favorite wellness podcaster or influencer, you’ve probably heard about peptides. These injectable compounds are comprised of a string of amino acids and promise effects like weight loss, better sleep, muscle growth and more.

Given the potential benefits, it comes as no surprise that interest has exploded. The market is ready to provide. It’s already valued around $140 billion and by 2033 is projected to reach over $290 billion in value.

Last month, an FDA advisory panel voted to make six peptides more accessible to the public. But scientists warned against this decision, saying there’s not enough data concerning their safety and effectiveness.

Many people are already getting their hands on peptides through what’s been called the gray market. What does the FDA’s decision mean for access? And how safe are they really?

Find more of our programs online. Listen to 1A sponsor-free by signing up for 1A+ at plus.npr.org/the1a.

See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.

NPR Privacy Policy

Medicine: The Problems And Possibilities...